NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results

Go back to NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results

NovaBay Pharma (NBY) Misses Q4 EPS by 15c

August 13, 2024 4:22 PM EDT

NovaBay Pharma (NYSE: NBY) reported Q4 EPS of ($1.37), $0.15 worse than the analyst estimate of ($1.22). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $3.15 million.

For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.

... More